A phase I dose-escalation study of BIBH-1 in patients with advanced or metastatic fibroblast activation protein positive cancer. Conference Paper uri icon

authors

  • Scott, AM
  • Wiseman, G
  • Welt, S
  • Lee, FT
  • Hopkins, W
  • Mitchell, P
  • Adjei, A
  • Divgi, CR
  • Larson, SM
  • Hoffman, EW
  • Tanswell, P
  • Bette, P
  • Vlock, D
  • Amelsberg, A
  • Rettig, W
  • Old, LJ

publication date

  • May 1, 2001